Form 4: Assertio Holdings Director, David Stark, Receives Stock and Options as Part of Board Appointment

David Stark, a director at Assertio Holdings, received 53,750 restricted stock units and 81,225 stock options as part of his initial board appointment.

Summary

• David Stark, a director at Assertio Holdings, received 53,750 restricted stock units and 81,225 stock options.
• The stock and options were granted as part of his initial appointment to the Board of Directors.
• The grants are in accordance with the company's Nonemployee Director Compensation & Grant Policy.
• One-third of the restricted stock units and stock options are scheduled to vest on each of November 7, 2025, 2026, and 2027, assuming continued service.
• The stock options have an exercise price of $1.01.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of director compensation, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grants align director compensation with company performance and long-term value creation.
• The vesting schedule encourages continued service and commitment from the director.

Risks

• The value of the stock options is dependent on the future performance of the company's stock price.
• The vesting of the stock and options is contingent on continued service, which could be impacted by unforeseen circumstances.

Future Outlook

The vesting of the stock and options is contingent on continued service through the applicable vesting dates.

Industry Context

Granting stock and options to board members is a common practice to align their interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• The practice of granting stock options and restricted stock units to directors is standard across the pharmaceutical and biotech industries.
• Companies like Teva Pharmaceuticals and Mylan (now Viatris) also use similar equity-based compensation for their board members.
• The vesting schedule of one-third per year is also a common practice to ensure long-term commitment from directors.

Stakeholder Impact

• Shareholders may view the grants positively as they align director interests with company performance.
• The grants do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, restricted stock units, director compensation, board of directors, vesting, equity grants, ASRT, Assertio Holdings